In Pursuit of COVID-19 Treatment Strategies: Are We Triggering Antimicrobial Resistance?
Disaster Med Public Health Prep
.
2022 Aug;16(4):1285-1286.
doi: 10.1017/dmp.2020.492.
Epub 2020 Dec 22.
Authors
Furqan Khurshid Hashmi
1
,
Naveel Atif
2
,
Usman Rashid Malik
1
,
Fahad Saleem
3
,
Zineb Riboua
4
,
Mohamed Azmi Hassali
5
,
Muhammad Hammad Butt
6
,
Tauqeer Hussain Mallhi
7
,
Yusra Habib Khan
7
Affiliations
1
Punjab University College of Pharmacy, University of the Punjab, Allama Iqbal Campus, Lahore, Pakistan.
2
Center of Drug Safety and Policy Research, School of Pharmacy, Xi'an Jiaotong University, Xi'an, Shaanxi, China.
3
Faculty of Pharmacy, University of Balochistan, Quetta, Balochistan, Pakistan.
4
McCourt School of Public Policy, Georgetown University, Washington DC, USA.
5
School of Pharmaceutical Sciences, Universiti Sains Malaysia, Penang, Malaysia.
6
Faculty of Pharmacy, University of Central Punjab, Lahore, Punjab, Pakistan.
7
Department of Clinical Pharmacy, College of Pharmacy, Jouf University, Kingdom of Saudi Arabia.
PMID:
33691830
PMCID:
PMC7985633
DOI:
10.1017/dmp.2020.492
No abstract available
Publication types
Letter
MeSH terms
Anti-Bacterial Agents / pharmacology
Anti-Bacterial Agents / therapeutic use
COVID-19 Drug Treatment
COVID-19*
Drug Resistance, Bacterial
Humans
SARS-CoV-2
Substances
Anti-Bacterial Agents